Geron Corp (NASDAQ:GERN)

3.53
Delayed Data
As of May 18
 +0.15 / +4.44%
Today’s Change
1.74
Today|||52-Week Range
6.68
+96.11%
Year-to-Date

Today’s Trading

Previous close3.38
Today’s open3.44
Day’s range3.38 - 3.55
Volume2,601,483
Average volume (3 months)5,833,124
Market cap$600.6M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+5.26%
Earnings growth (this year)+105.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.72%
P/E ratioNM
Price/Sales269.11
Price/Book5.34

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.12+5.33%
EDGEEdge Therapeutics In...-0.03-3.27%
AGENAgenus Inc+0.10+2.99%
BLCMBellicum Pharmaceuti...+0.01+0.13%
Data as of 6:30pm ET, 05/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$1.1M
Annual profit (last year)-$27.9M
Net profit margin-2,621.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts